Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 92 | 2024 | 6939 | 4.640 |
Why?
|
Hepacivirus | 39 | 2022 | 1378 | 3.540 |
Why?
|
CD8-Positive T-Lymphocytes | 77 | 2022 | 4477 | 3.440 |
Why?
|
Epitopes, T-Lymphocyte | 55 | 2019 | 880 | 3.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 50 | 2018 | 1821 | 3.020 |
Why?
|
HIV Infections | 92 | 2024 | 16715 | 2.730 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 16 | 2019 | 222 | 2.410 |
Why?
|
HLA-B Antigens | 26 | 2019 | 354 | 2.380 |
Why?
|
Virus Replication | 40 | 2019 | 2535 | 2.100 |
Why?
|
Hepatitis C | 26 | 2022 | 1591 | 1.940 |
Why?
|
Immunodominant Epitopes | 25 | 2015 | 267 | 1.760 |
Why?
|
Simian immunodeficiency virus | 28 | 2018 | 846 | 1.720 |
Why?
|
HLA-B27 Antigen | 13 | 2015 | 76 | 1.720 |
Why?
|
Viremia | 20 | 2021 | 736 | 1.470 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 23 | 2018 | 570 | 1.420 |
Why?
|
AIDS Vaccines | 18 | 2024 | 938 | 1.340 |
Why?
|
Viral Nonstructural Proteins | 10 | 2015 | 241 | 1.280 |
Why?
|
Histocompatibility Antigens Class I | 26 | 2019 | 1366 | 1.230 |
Why?
|
HIV | 16 | 2015 | 1604 | 1.100 |
Why?
|
Evolution, Molecular | 17 | 2016 | 1940 | 1.080 |
Why?
|
Drug Users | 3 | 2022 | 134 | 1.050 |
Why?
|
Immune Evasion | 7 | 2017 | 360 | 1.030 |
Why?
|
HIV Antibodies | 8 | 2024 | 1322 | 1.010 |
Why?
|
Genome, Viral | 11 | 2019 | 665 | 0.990 |
Why?
|
Viral Load | 38 | 2020 | 3300 | 0.950 |
Why?
|
Substance Abuse, Intravenous | 4 | 2022 | 525 | 0.870 |
Why?
|
Hepatitis C, Chronic | 14 | 2021 | 1029 | 0.800 |
Why?
|
HIV Envelope Protein gp41 | 2 | 2020 | 314 | 0.790 |
Why?
|
Superinfection | 4 | 2018 | 65 | 0.750 |
Why?
|
HIV Antigens | 10 | 2024 | 347 | 0.740 |
Why?
|
Antibodies, Neutralizing | 8 | 2020 | 1978 | 0.720 |
Why?
|
Phylogeny | 19 | 2022 | 2796 | 0.700 |
Why?
|
Gene Products, gag | 13 | 2009 | 337 | 0.690 |
Why?
|
Molecular Sequence Data | 54 | 2015 | 18107 | 0.690 |
Why?
|
Amino Acid Sequence | 53 | 2014 | 13809 | 0.670 |
Why?
|
Virus Internalization | 2 | 2020 | 501 | 0.650 |
Why?
|
Mutation | 32 | 2019 | 29777 | 0.640 |
Why?
|
Mutation, Missense | 7 | 2015 | 2566 | 0.630 |
Why?
|
Selection, Genetic | 9 | 2017 | 914 | 0.620 |
Why?
|
Disease Models, Animal | 13 | 2021 | 18027 | 0.620 |
Why?
|
CD4-Positive T-Lymphocytes | 21 | 2022 | 4386 | 0.610 |
Why?
|
T-Lymphocytes | 14 | 2020 | 10179 | 0.610 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 2019 | 2232 | 0.580 |
Why?
|
SAIDS Vaccines | 8 | 2018 | 166 | 0.580 |
Why?
|
Interferon Type I | 2 | 2017 | 541 | 0.560 |
Why?
|
HIV Core Protein p24 | 9 | 2022 | 256 | 0.540 |
Why?
|
RNA, Viral | 20 | 2019 | 2901 | 0.540 |
Why?
|
Drug Resistance, Viral | 4 | 2012 | 820 | 0.540 |
Why?
|
Genes, MHC Class I | 12 | 2014 | 258 | 0.510 |
Why?
|
Macaca mulatta | 34 | 2018 | 2375 | 0.500 |
Why?
|
Protease Inhibitors | 2 | 2009 | 792 | 0.500 |
Why?
|
Antiviral Agents | 13 | 2021 | 2984 | 0.470 |
Why?
|
Immune System | 1 | 2019 | 807 | 0.460 |
Why?
|
Epitopes | 16 | 2024 | 2570 | 0.460 |
Why?
|
Genetic Variation | 18 | 2019 | 6535 | 0.440 |
Why?
|
Amino Acid Substitution | 10 | 2018 | 1793 | 0.430 |
Why?
|
Models, Animal | 1 | 2019 | 2172 | 0.430 |
Why?
|
Vaccines, DNA | 7 | 2007 | 305 | 0.430 |
Why?
|
Genetic Fitness | 1 | 2013 | 121 | 0.400 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1271 | 0.400 |
Why?
|
Suppression, Genetic | 1 | 2011 | 196 | 0.390 |
Why?
|
CD4 Lymphocyte Count | 18 | 2019 | 2560 | 0.380 |
Why?
|
Polymorphism, Genetic | 8 | 2013 | 4326 | 0.360 |
Why?
|
HIV Envelope Protein gp120 | 4 | 2024 | 952 | 0.360 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9731 | 0.360 |
Why?
|
Mice, SCID | 6 | 2021 | 2718 | 0.350 |
Why?
|
Humans | 172 | 2024 | 743811 | 0.350 |
Why?
|
Antigen Presentation | 6 | 2010 | 1283 | 0.340 |
Why?
|
Antigens, Viral | 6 | 2021 | 1035 | 0.340 |
Why?
|
HLA Antigens | 10 | 2016 | 1382 | 0.340 |
Why?
|
Capsid | 3 | 2011 | 437 | 0.330 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2010 | 1369 | 0.330 |
Why?
|
Immunologic Memory | 3 | 2021 | 1347 | 0.330 |
Why?
|
Sequence Alignment | 10 | 2012 | 2256 | 0.330 |
Why?
|
Alleles | 20 | 2019 | 6934 | 0.330 |
Why?
|
Gene Products, env | 5 | 2018 | 263 | 0.310 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2016 | 805 | 0.300 |
Why?
|
Animals | 68 | 2022 | 168660 | 0.300 |
Why?
|
Mice | 22 | 2022 | 81154 | 0.300 |
Why?
|
Immunity, Cellular | 11 | 2016 | 1608 | 0.290 |
Why?
|
Biological Evolution | 3 | 2021 | 1079 | 0.280 |
Why?
|
Sequence Analysis, RNA | 7 | 2019 | 2009 | 0.280 |
Why?
|
Acute Disease | 14 | 2019 | 7150 | 0.270 |
Why?
|
Viral Proteins | 11 | 2008 | 1899 | 0.270 |
Why?
|
Gene Products, nef | 6 | 2018 | 110 | 0.270 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 5 | 2019 | 153 | 0.260 |
Why?
|
Drug Discovery | 1 | 2013 | 1058 | 0.260 |
Why?
|
DNA Primers | 8 | 2015 | 2891 | 0.260 |
Why?
|
Metagenomics | 2 | 2019 | 428 | 0.260 |
Why?
|
HLA-B8 Antigen | 1 | 2004 | 19 | 0.260 |
Why?
|
Epitope Mapping | 8 | 2007 | 311 | 0.250 |
Why?
|
Vaccinia virus | 4 | 2002 | 349 | 0.250 |
Why?
|
Open Reading Frames | 1 | 2008 | 811 | 0.250 |
Why?
|
Base Sequence | 17 | 2015 | 12798 | 0.250 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 4803 | 0.250 |
Why?
|
Capsid Proteins | 1 | 2008 | 479 | 0.250 |
Why?
|
Genes, gag | 5 | 2011 | 61 | 0.250 |
Why?
|
HLA-C Antigens | 3 | 2014 | 147 | 0.240 |
Why?
|
Mucous Membrane | 2 | 2019 | 669 | 0.240 |
Why?
|
Recombination, Genetic | 5 | 2011 | 1586 | 0.230 |
Why?
|
Endotoxemia | 2 | 2015 | 207 | 0.230 |
Why?
|
Gene Products, tat | 4 | 2006 | 120 | 0.230 |
Why?
|
Adaptation, Physiological | 3 | 2016 | 1311 | 0.220 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2013 | 1872 | 0.220 |
Why?
|
Flow Cytometry | 11 | 2015 | 5973 | 0.220 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 3 | 2024 | 371 | 0.220 |
Why?
|
Interferon-gamma | 14 | 2012 | 3205 | 0.220 |
Why?
|
Genotype | 11 | 2016 | 12944 | 0.220 |
Why?
|
Amino Acids | 3 | 2024 | 1733 | 0.220 |
Why?
|
Killer Cells, Natural | 4 | 2014 | 2131 | 0.210 |
Why?
|
Needle Sharing | 1 | 2022 | 24 | 0.210 |
Why?
|
End Stage Liver Disease | 2 | 2016 | 314 | 0.210 |
Why?
|
HIV Seropositivity | 2 | 2024 | 971 | 0.200 |
Why?
|
Polymerase Chain Reaction | 8 | 2016 | 6170 | 0.200 |
Why?
|
Genes, Reporter | 1 | 2005 | 1545 | 0.200 |
Why?
|
Thymus Gland | 2 | 2020 | 1266 | 0.190 |
Why?
|
Viral Regulatory and Accessory Proteins | 3 | 2019 | 159 | 0.190 |
Why?
|
Lymphocyte Activation | 9 | 2017 | 5524 | 0.190 |
Why?
|
Methamphetamine | 1 | 2022 | 154 | 0.190 |
Why?
|
Vagina | 2 | 2019 | 825 | 0.180 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1876 | 0.180 |
Why?
|
Consensus Sequence | 6 | 2014 | 378 | 0.180 |
Why?
|
Receptors, CXCR4 | 2 | 2020 | 727 | 0.180 |
Why?
|
Human Immunodeficiency Virus Proteins | 4 | 2019 | 65 | 0.180 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2086 | 0.180 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2016 | 2540 | 0.180 |
Why?
|
Proline | 4 | 2021 | 457 | 0.170 |
Why?
|
Viral Vaccines | 4 | 2012 | 636 | 0.170 |
Why?
|
Chronic Disease | 12 | 2016 | 9139 | 0.170 |
Why?
|
Receptors, CCR5 | 3 | 2014 | 498 | 0.160 |
Why?
|
Gene Products, vif | 1 | 2018 | 33 | 0.160 |
Why?
|
HIV Long-Term Survivors | 4 | 2012 | 126 | 0.160 |
Why?
|
Conserved Sequence | 5 | 2019 | 1202 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2007 | 2839 | 0.160 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2012 | 323 | 0.150 |
Why?
|
Sexual Partners | 1 | 2022 | 728 | 0.150 |
Why?
|
Cyclosporine | 2 | 2013 | 788 | 0.150 |
Why?
|
Peptides | 9 | 2011 | 4406 | 0.150 |
Why?
|
Saguinus | 2 | 1997 | 17 | 0.150 |
Why?
|
Immunization, Passive | 2 | 2017 | 623 | 0.150 |
Why?
|
Lymphoid Tissue | 2 | 2022 | 454 | 0.150 |
Why?
|
beta-Defensins | 1 | 2017 | 57 | 0.150 |
Why?
|
DNA, Viral | 3 | 2012 | 2226 | 0.140 |
Why?
|
Antibodies, Viral | 4 | 2018 | 3175 | 0.140 |
Why?
|
Hepatitis Viruses | 1 | 2016 | 17 | 0.140 |
Why?
|
Arsenicals | 1 | 1996 | 124 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 82 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2017 | 3874 | 0.140 |
Why?
|
Disease Progression | 10 | 2018 | 13273 | 0.130 |
Why?
|
Host-Pathogen Interactions | 4 | 2019 | 1479 | 0.130 |
Why?
|
Nanocapsules | 1 | 2016 | 92 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2016 | 1475 | 0.130 |
Why?
|
Antibodies, Blocking | 2 | 2013 | 253 | 0.130 |
Why?
|
Phenylenediamines | 1 | 2016 | 90 | 0.130 |
Why?
|
Liver | 5 | 2020 | 7479 | 0.130 |
Why?
|
Metagenome | 1 | 2019 | 418 | 0.130 |
Why?
|
Drug Design | 3 | 2006 | 1075 | 0.130 |
Why?
|
Cohort Studies | 20 | 2016 | 40545 | 0.130 |
Why?
|
Dengue Virus | 1 | 2017 | 204 | 0.130 |
Why?
|
Oligopeptides | 4 | 2008 | 1188 | 0.130 |
Why?
|
Germany | 2 | 2009 | 862 | 0.130 |
Why?
|
Immunization | 1 | 2019 | 1255 | 0.130 |
Why?
|
Anti-HIV Agents | 3 | 2016 | 4255 | 0.120 |
Why?
|
Genome-Wide Association Study | 3 | 2013 | 12259 | 0.120 |
Why?
|
STAT1 Transcription Factor | 1 | 2015 | 320 | 0.120 |
Why?
|
Species Specificity | 5 | 2011 | 2480 | 0.120 |
Why?
|
Autoantigens | 2 | 2016 | 892 | 0.120 |
Why?
|
Male | 52 | 2021 | 349776 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 1157 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2020 | 4204 | 0.120 |
Why?
|
HIV Seronegativity | 1 | 2014 | 211 | 0.110 |
Why?
|
Lymphocyte Subsets | 1 | 2014 | 315 | 0.110 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 623 | 0.110 |
Why?
|
Interferons | 1 | 2016 | 706 | 0.110 |
Why?
|
Point Mutation | 4 | 2014 | 1623 | 0.110 |
Why?
|
Heterosexuality | 1 | 2014 | 275 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 3389 | 0.110 |
Why?
|
Anti-Retroviral Agents | 3 | 2014 | 1714 | 0.100 |
Why?
|
Dependovirus | 1 | 2017 | 705 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2011 | 16 | 0.100 |
Why?
|
Genomic Structural Variation | 1 | 2012 | 64 | 0.100 |
Why?
|
HLA-A Antigens | 3 | 2010 | 232 | 0.100 |
Why?
|
Genes, vif | 1 | 2011 | 17 | 0.100 |
Why?
|
Recurrence | 4 | 2021 | 8337 | 0.100 |
Why?
|
Receptors, KIR | 2 | 2011 | 113 | 0.100 |
Why?
|
Thermodynamics | 1 | 2013 | 595 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 4 | 2009 | 1836 | 0.100 |
Why?
|
Up-Regulation | 3 | 2017 | 4221 | 0.100 |
Why?
|
Cell Line | 9 | 2011 | 15993 | 0.090 |
Why?
|
Sulfonamides | 2 | 2021 | 1938 | 0.090 |
Why?
|
Female | 50 | 2021 | 380020 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9272 | 0.090 |
Why?
|
Sampling Studies | 1 | 2011 | 622 | 0.090 |
Why?
|
HIV Reverse Transcriptase | 1 | 2011 | 213 | 0.090 |
Why?
|
Peptide Fragments | 3 | 2020 | 5096 | 0.090 |
Why?
|
Bone Marrow | 1 | 2020 | 2951 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1344 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2019 | 3591 | 0.090 |
Why?
|
HIV Integrase | 1 | 2011 | 120 | 0.090 |
Why?
|
Plasmids | 2 | 2013 | 2308 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2011 | 166 | 0.090 |
Why?
|
Bed Occupancy | 1 | 2009 | 41 | 0.090 |
Why?
|
Cells, Cultured | 12 | 2014 | 19232 | 0.090 |
Why?
|
Antibody Affinity | 2 | 2008 | 254 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2013 | 1723 | 0.090 |
Why?
|
Phenylthiourea | 1 | 2008 | 11 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2014 | 4422 | 0.080 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2008 | 39 | 0.080 |
Why?
|
Lymphocyte Count | 3 | 2006 | 793 | 0.080 |
Why?
|
Vaccines, Attenuated | 2 | 2000 | 342 | 0.080 |
Why?
|
Ribavirin | 3 | 2021 | 394 | 0.080 |
Why?
|
Pan troglodytes | 2 | 2014 | 229 | 0.080 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2005 | 87 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 2017 | 7719 | 0.080 |
Why?
|
Cytokines | 5 | 2016 | 7324 | 0.080 |
Why?
|
Lactones | 1 | 2011 | 329 | 0.080 |
Why?
|
Genes, nef | 2 | 2008 | 55 | 0.080 |
Why?
|
Macrocyclic Compounds | 1 | 2008 | 72 | 0.080 |
Why?
|
Antigens, CD | 2 | 2010 | 4026 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 12066 | 0.080 |
Why?
|
Genes, env | 1 | 2008 | 95 | 0.080 |
Why?
|
Adult | 32 | 2021 | 213889 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 593 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2011 | 613 | 0.080 |
Why?
|
Cloning, Molecular | 2 | 2013 | 4320 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2016 | 370 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2217 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3645 | 0.080 |
Why?
|
Cyclophilin A | 1 | 2007 | 57 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2064 | 0.080 |
Why?
|
Liver Transplantation | 2 | 2016 | 2119 | 0.070 |
Why?
|
Cervix Uteri | 1 | 2011 | 590 | 0.070 |
Why?
|
Carbamates | 1 | 2008 | 196 | 0.070 |
Why?
|
Hepatitis B Core Antigens | 1 | 2007 | 92 | 0.070 |
Why?
|
Myeloid Cells | 2 | 2012 | 808 | 0.070 |
Why?
|
Histocompatibility Testing | 1 | 2009 | 741 | 0.070 |
Why?
|
Young Adult | 9 | 2022 | 56392 | 0.070 |
Why?
|
Gene Deletion | 1 | 2014 | 2749 | 0.070 |
Why?
|
Monocytes | 3 | 2017 | 2593 | 0.070 |
Why?
|
Homosexuality, Male | 1 | 2014 | 1240 | 0.070 |
Why?
|
Cell Movement | 1 | 2019 | 5216 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3515 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2015 | 5445 | 0.070 |
Why?
|
Vaccination | 5 | 2015 | 3275 | 0.070 |
Why?
|
Virus Latency | 1 | 2008 | 358 | 0.070 |
Why?
|
5' Untranslated Regions | 1 | 2007 | 249 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2007 | 1085 | 0.070 |
Why?
|
Gene Products, pol | 2 | 2002 | 47 | 0.070 |
Why?
|
Adjuvants, Immunologic | 2 | 2022 | 999 | 0.070 |
Why?
|
Multigene Family | 1 | 2009 | 1101 | 0.070 |
Why?
|
Virology | 1 | 2005 | 76 | 0.070 |
Why?
|
Virion | 1 | 2007 | 433 | 0.060 |
Why?
|
Waiting Lists | 1 | 2009 | 692 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 3504 | 0.060 |
Why?
|
HLA-A3 Antigen | 1 | 2004 | 34 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2005 | 985 | 0.060 |
Why?
|
HLA-A2 Antigen | 1 | 2005 | 213 | 0.060 |
Why?
|
Protein Conformation | 3 | 2010 | 4009 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1023 | 0.060 |
Why?
|
Foot Deformities, Congenital | 2 | 1994 | 59 | 0.060 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2009 | 1320 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3587 | 0.060 |
Why?
|
Genome, Human | 2 | 2014 | 4418 | 0.060 |
Why?
|
Receptors, KIR2DL2 | 2 | 2014 | 7 | 0.060 |
Why?
|
Quinolines | 1 | 2008 | 732 | 0.060 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 1994 | 322 | 0.060 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2003 | 97 | 0.060 |
Why?
|
Hand Deformities, Congenital | 2 | 1994 | 146 | 0.060 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2003 | 71 | 0.060 |
Why?
|
Pseudogenes | 1 | 2003 | 113 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3917 | 0.060 |
Why?
|
Remission, Spontaneous | 3 | 2012 | 382 | 0.060 |
Why?
|
Binding Sites | 1 | 2011 | 6111 | 0.050 |
Why?
|
Cross Reactions | 3 | 2011 | 841 | 0.050 |
Why?
|
Algorithms | 3 | 2012 | 13869 | 0.050 |
Why?
|
Prospective Studies | 4 | 2022 | 53250 | 0.050 |
Why?
|
Africa, Southern | 2 | 2016 | 57 | 0.050 |
Why?
|
2-Naphthylamine | 1 | 2021 | 23 | 0.050 |
Why?
|
Poly I-C | 1 | 2022 | 114 | 0.050 |
Why?
|
Middle Aged | 21 | 2021 | 213241 | 0.050 |
Why?
|
Immunization, Secondary | 2 | 2002 | 340 | 0.050 |
Why?
|
Adaptive Immunity | 2 | 2017 | 715 | 0.050 |
Why?
|
Spondylitis | 1 | 2001 | 22 | 0.050 |
Why?
|
Thiazoles | 1 | 2008 | 1482 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1098 | 0.050 |
Why?
|
Wisconsin | 1 | 2021 | 124 | 0.050 |
Why?
|
Models, Immunological | 2 | 2016 | 527 | 0.050 |
Why?
|
Cyclohexanones | 1 | 2000 | 30 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2013 | 2958 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2016 | 21733 | 0.050 |
Why?
|
Biolistics | 1 | 2000 | 19 | 0.050 |
Why?
|
High Mobility Group Proteins | 1 | 2021 | 187 | 0.050 |
Why?
|
Leukocytes | 1 | 2009 | 2044 | 0.050 |
Why?
|
Macaca | 1 | 2002 | 439 | 0.050 |
Why?
|
Arthritis, Reactive | 1 | 2000 | 19 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2018 | 2712 | 0.050 |
Why?
|
Adenine | 1 | 2006 | 935 | 0.050 |
Why?
|
Antigenic Variation | 3 | 2006 | 125 | 0.050 |
Why?
|
Time Factors | 6 | 2017 | 40038 | 0.050 |
Why?
|
Zidovudine | 1 | 2002 | 620 | 0.050 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2000 | 143 | 0.050 |
Why?
|
Genes, Viral | 3 | 2011 | 718 | 0.050 |
Why?
|
Uracil | 1 | 2021 | 165 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4665 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2021 | 415 | 0.040 |
Why?
|
Neutralization Tests | 2 | 2017 | 757 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2001 | 3038 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15518 | 0.040 |
Why?
|
Dysentery, Bacillary | 1 | 2000 | 75 | 0.040 |
Why?
|
Valine | 1 | 2021 | 413 | 0.040 |
Why?
|
Lactams, Macrocyclic | 1 | 2021 | 319 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14714 | 0.040 |
Why?
|
Ritonavir | 1 | 2021 | 322 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4286 | 0.040 |
Why?
|
Protein Binding | 4 | 2011 | 9377 | 0.040 |
Why?
|
Shigella flexneri | 1 | 2000 | 132 | 0.040 |
Why?
|
Prisons | 1 | 2021 | 161 | 0.040 |
Why?
|
Culicidae | 1 | 2019 | 104 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 2019 | 427 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 409 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2015 | 39001 | 0.040 |
Why?
|
Immunity, Mucosal | 1 | 2001 | 490 | 0.040 |
Why?
|
p21-Activated Kinases | 1 | 2019 | 128 | 0.040 |
Why?
|
Cell Proliferation | 5 | 2015 | 10477 | 0.040 |
Why?
|
Lassa Fever | 1 | 2019 | 97 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1129 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 627 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2931 | 0.040 |
Why?
|
Arginine | 1 | 2001 | 943 | 0.040 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1996 | 220 | 0.040 |
Why?
|
Organ Specificity | 1 | 2001 | 2008 | 0.040 |
Why?
|
Cell Lineage | 2 | 2016 | 2506 | 0.040 |
Why?
|
Hydrazones | 1 | 1997 | 102 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2022 | 2720 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4749 | 0.030 |
Why?
|
Macrophages | 1 | 2011 | 5651 | 0.030 |
Why?
|
Software | 1 | 2010 | 4440 | 0.030 |
Why?
|
Interferon-alpha | 2 | 2014 | 895 | 0.030 |
Why?
|
Haplotypes | 2 | 2014 | 2779 | 0.030 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2016 | 132 | 0.030 |
Why?
|
Gene Library | 1 | 2019 | 1074 | 0.030 |
Why?
|
Nigeria | 1 | 2019 | 733 | 0.030 |
Why?
|
British Columbia | 1 | 2016 | 244 | 0.030 |
Why?
|
Computer Simulation | 1 | 2009 | 6188 | 0.030 |
Why?
|
Mesna | 1 | 1995 | 66 | 0.030 |
Why?
|
Genetic Testing | 1 | 2008 | 3439 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2019 | 572 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 2016 | 402 | 0.030 |
Why?
|
Arthritis | 1 | 2001 | 661 | 0.030 |
Why?
|
Receptors, KIR2DL1 | 1 | 2014 | 15 | 0.030 |
Why?
|
Receptors, KIR2DL3 | 1 | 2014 | 17 | 0.030 |
Why?
|
Clone Cells | 3 | 2005 | 1692 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 1998 | 936 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 284 | 0.030 |
Why?
|
Oxides | 1 | 1996 | 405 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4568 | 0.030 |
Why?
|
Proteome | 2 | 2019 | 1794 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2014 | 4183 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 3 | 2010 | 1837 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 504 | 0.030 |
Why?
|
England | 1 | 2016 | 522 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 968 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12354 | 0.030 |
Why?
|
Ketones | 1 | 1995 | 187 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 471 | 0.030 |
Why?
|
Immunity, Innate | 3 | 2015 | 2961 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2013 | 87 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1995 | 437 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7880 | 0.030 |
Why?
|
South Africa | 1 | 2019 | 1731 | 0.030 |
Why?
|
RNA Editing | 1 | 2014 | 148 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10394 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 967 | 0.030 |
Why?
|
Phenotype | 4 | 2021 | 16361 | 0.030 |
Why?
|
Virus Diseases | 1 | 2019 | 711 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2014 | 658 | 0.030 |
Why?
|
West Nile virus | 1 | 2012 | 79 | 0.030 |
Why?
|
Perforin | 1 | 2012 | 168 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2017 | 63042 | 0.030 |
Why?
|
Toll-Like Receptor 8 | 1 | 2012 | 89 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 165 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2011 | 150 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12243 | 0.020 |
Why?
|
Gene Targeting | 1 | 2014 | 879 | 0.020 |
Why?
|
Transplantation | 1 | 2013 | 217 | 0.020 |
Why?
|
Actins | 1 | 2019 | 2121 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1996 | 2183 | 0.020 |
Why?
|
Plasma | 1 | 2014 | 575 | 0.020 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.020 |
Why?
|
Toll-Like Receptor 7 | 1 | 2012 | 171 | 0.020 |
Why?
|
Thailand | 1 | 2011 | 299 | 0.020 |
Why?
|
Lymphocytes | 1 | 2019 | 2615 | 0.020 |
Why?
|
Models, Molecular | 2 | 2011 | 5445 | 0.020 |
Why?
|
Interleukins | 1 | 2015 | 791 | 0.020 |
Why?
|
Antineoplastic Agents | 3 | 2000 | 13691 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2011 | 549 | 0.020 |
Why?
|
Family Characteristics | 1 | 2015 | 1000 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7658 | 0.020 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2009 | 52 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1018 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2883 | 0.020 |
Why?
|
Decision Trees | 1 | 2011 | 506 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2019 | 1771 | 0.020 |
Why?
|
HLA-B35 Antigen | 1 | 2008 | 8 | 0.020 |
Why?
|
Aged | 9 | 2017 | 163178 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 1994 | 4737 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17439 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1707 | 0.020 |
Why?
|
Genes, pol | 1 | 2008 | 51 | 0.020 |
Why?
|
Fatigue | 1 | 2016 | 1530 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 813 | 0.020 |
Why?
|
Peru | 1 | 2011 | 882 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 546 | 0.020 |
Why?
|
Sequence Homology | 1 | 2008 | 203 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2013 | 13980 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2013 | 14563 | 0.020 |
Why?
|
Receptors, HIV | 1 | 2009 | 163 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2011 | 733 | 0.020 |
Why?
|
Cell Polarity | 1 | 2011 | 645 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2021 | 11478 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2603 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1994 | 1811 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 897 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2008 | 258 | 0.020 |
Why?
|
Piperidines | 1 | 1995 | 1601 | 0.020 |
Why?
|
Virulence | 1 | 2011 | 1328 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1994 | 1416 | 0.020 |
Why?
|
Leukemia P388 | 2 | 1997 | 16 | 0.020 |
Why?
|
Serotyping | 1 | 2007 | 338 | 0.020 |
Why?
|
Codon | 1 | 2008 | 611 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1656 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2000 | 729 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2011 | 971 | 0.020 |
Why?
|
Vero Cells | 1 | 2007 | 485 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3677 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2007 | 287 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1995 | 1709 | 0.020 |
Why?
|
Immunotherapy, Active | 1 | 2006 | 60 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1374 | 0.020 |
Why?
|
Gene Products, vpr | 1 | 2005 | 36 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2000 | 6311 | 0.020 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2005 | 39 | 0.020 |
Why?
|
Genetic Loci | 1 | 2014 | 2575 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2012 | 1904 | 0.020 |
Why?
|
Viral Structural Proteins | 1 | 2004 | 103 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 77410 | 0.020 |
Why?
|
Phosphorylation | 1 | 2015 | 8436 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1799 | 0.020 |
Why?
|
Repressor Proteins | 1 | 1995 | 3024 | 0.010 |
Why?
|
Trauma Centers | 1 | 2009 | 891 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8316 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2203 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 645 | 0.010 |
Why?
|
Hepatitis, Viral, Animal | 1 | 2003 | 12 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2008 | 1524 | 0.010 |
Why?
|
Crystallography, X-Ray | 2 | 2000 | 2011 | 0.010 |
Why?
|
Internationality | 1 | 2009 | 1002 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6976 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 751 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5714 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3706 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6620 | 0.010 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 127 | 0.010 |
Why?
|
Administration, Rectal | 1 | 2001 | 72 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15211 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7793 | 0.010 |
Why?
|
United States | 2 | 2009 | 69859 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 758 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2006 | 599 | 0.010 |
Why?
|
Gorilla gorilla | 1 | 2001 | 30 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9440 | 0.010 |
Why?
|
Immunotherapy | 1 | 2016 | 4437 | 0.010 |
Why?
|
Caspases | 1 | 2004 | 928 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2004 | 1004 | 0.010 |
Why?
|
Infant | 3 | 2009 | 35122 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1995 | 5854 | 0.010 |
Why?
|
Chimera | 1 | 2001 | 484 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2002 | 399 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4561 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 25032 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2004 | 1802 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1181 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6476 | 0.010 |
Why?
|
Adolescent | 4 | 2009 | 85729 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5100 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2369 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2004 | 1880 | 0.010 |
Why?
|
Vaccines, Synthetic | 1 | 2001 | 634 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2760 | 0.010 |
Why?
|
Antibody Formation | 1 | 2003 | 1402 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21824 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 936 | 0.010 |
Why?
|
China | 1 | 2004 | 2243 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1998 | 329 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1422 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6380 | 0.010 |
Why?
|
Genetic Markers | 2 | 1994 | 2634 | 0.010 |
Why?
|
Reassortant Viruses | 1 | 1997 | 37 | 0.010 |
Why?
|
Gene Frequency | 1 | 2004 | 3585 | 0.010 |
Why?
|
Leukemia L1210 | 1 | 1997 | 45 | 0.010 |
Why?
|
Chick Embryo | 1 | 1999 | 983 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2007 | 3421 | 0.010 |
Why?
|
Nucleoproteins | 1 | 1997 | 115 | 0.010 |
Why?
|
Rectum | 1 | 2001 | 904 | 0.010 |
Why?
|
Viral Matrix Proteins | 1 | 1997 | 186 | 0.010 |
Why?
|
Molecular Structure | 1 | 2000 | 1894 | 0.010 |
Why?
|
Length of Stay | 1 | 2009 | 6311 | 0.010 |
Why?
|
Mannich Bases | 1 | 1995 | 3 | 0.010 |
Why?
|
Viral Envelope Proteins | 1 | 1999 | 635 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13404 | 0.010 |
Why?
|
Transcription Factors | 1 | 1995 | 12209 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2010 | 57744 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6487 | 0.010 |
Why?
|
Orthomyxoviridae Infections | 1 | 1997 | 247 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1995 | 878 | 0.010 |
Why?
|
Child, Preschool | 2 | 2009 | 40964 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 1994 | 143 | 0.010 |
Why?
|
Centromere | 1 | 1995 | 220 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1994 | 441 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1995 | 561 | 0.010 |
Why?
|
Chromosome Inversion | 1 | 1994 | 127 | 0.010 |
Why?
|
Influenza A virus | 1 | 1997 | 457 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1994 | 803 | 0.010 |
Why?
|
Melphalan | 1 | 1995 | 431 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3772 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1781 | 0.010 |
Why?
|
Comorbidity | 1 | 2006 | 10380 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 2050 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15067 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1994 | 880 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1994 | 510 | 0.010 |
Why?
|
Cricetinae | 1 | 1994 | 2475 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2002 | 3476 | 0.010 |
Why?
|
Child | 3 | 2005 | 77637 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1994 | 1396 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 1995 | 1148 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 1994 | 1420 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1994 | 2649 | 0.000 |
Why?
|
Syndrome | 1 | 1994 | 3249 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1995 | 20827 | 0.000 |
Why?
|
Risk Factors | 1 | 2014 | 72252 | 0.000 |
Why?
|
Prognosis | 1 | 2007 | 29052 | 0.000 |
Why?
|
RNA | 1 | 1995 | 2748 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1995 | 3758 | 0.000 |
Why?
|
Proteins | 1 | 1995 | 6098 | 0.000 |
Why?
|
Rats | 1 | 1995 | 24250 | 0.000 |
Why?
|